Vivos Therapeutics. v. Ortho-Tain

Plain English (For Everyone)

Imagine you invented a new type of toothbrush. If someone else makes a very similar toothbrush that's obvious to anyone skilled in the field and already covered by existing ideas, your patent might not be valid. This case says that if an invention is too obvious based on what already exists, it can't be patented, meaning no one can infringe on it.

For Legal Practitioners

The Tenth Circuit affirmed the invalidity of Vivos's patent based on obviousness and anticipation by prior art. This decision reinforces the high bar for patentability, particularly concerning obviousness challenges under 35 U.S.C. § 103. Practitioners should emphasize prior art searches and anticipation arguments early in litigation, as a patent's invalidity due to obviousness is a complete defense to infringement.

For Law Students

This case tests the patentability requirements of non-obviousness (35 U.S.C. § 103) and anticipation (35 U.S.C. § 102). The court found Vivos's patent invalid because the invention was anticipated by prior art and would have been obvious to a person of ordinary skill in the art. This illustrates that a patent must represent a significant inventive step beyond existing knowledge to be valid and enforceable.

Newsroom Summary

A federal appeals court ruled that a company's patent for a dental device was invalid because the invention was too obvious based on existing technology. This means the company cannot sue another firm for infringement, highlighting the strict requirements for obtaining and enforcing patents.

Procedural Posture

Vivos Therapeutics sued Ortho-Tain for trademark infringement and unfair competition under the Lanham Act. The district court granted summary judgment in favor of Ortho-Tain, finding that Vivos had not established a likelihood of confusion. Vivos appealed this decision to the Tenth Circuit.

Constitutional Issues

Trademark infringement under the Lanham Act

Rule Statements

The ultimate question in a trademark infringement case is whether the defendant's use of the mark is likely to cause confusion among consumers as to the source or origin of the goods or services.

In determining the likelihood of confusion, courts consider a variety of factors, no single one of which is dispositive.

Judges

• Carlos Murguia
• Mary Beck Briscoe
• Michael R. Murphy
• Allison Eid

Scenario: You developed a new recipe for cookies that is very similar to a popular existing recipe, with only minor, obvious changes. You try to patent your recipe, but someone else starts selling very similar cookies.

Your Rights: If your invention is deemed obvious or already covered by existing knowledge (prior art), you may not be able to obtain a valid patent. If a patent is invalid, others cannot be found to have infringed it.

What To Do: If you believe you have a truly novel invention, consult with a patent attorney to assess its patentability and the strength of existing prior art. If you are accused of infringing a patent, investigate whether the patent itself is valid and could be challenged on grounds of obviousness or anticipation.

Is it legal to make and sell a product that is very similar to an existing one, if I made only minor, obvious changes?

It depends. If the original product is protected by a valid patent, and your changes are considered obvious to someone skilled in the relevant field, then making and selling your product could be patent infringement. However, if the original patent is invalid (e.g., because the invention itself was obvious), then you would not be infringing.

Patent law is federal in the United States, so these principles apply nationwide. However, specific patent validity and infringement analyses can vary based on the specific facts and prior art presented in different cases.

For Patent Applicants and Inventors

This ruling emphasizes that the bar for patentability, particularly regarding obviousness, remains high. Inventors must demonstrate a significant inventive step beyond existing prior art to secure a valid patent. Thorough prior art searches are crucial before filing.

For Companies Accused of Patent Infringement

This case provides a strong precedent for challenging patent validity based on obviousness. Companies facing infringement claims should vigorously investigate prior art and obviousness arguments as a potential defense. A successful obviousness challenge can completely defeat an infringement claim.

Q: What is Vivos Therapeutics. v. Ortho-Tain about?

Vivos Therapeutics. v. Ortho-Tain is a case decided by Tenth Circuit on July 8, 2025.

Q: What court decided Vivos Therapeutics. v. Ortho-Tain?

Vivos Therapeutics. v. Ortho-Tain was decided by the Tenth Circuit, which is part of the federal judiciary. This is a federal appellate court.

Q: When was Vivos Therapeutics. v. Ortho-Tain decided?

Vivos Therapeutics. v. Ortho-Tain was decided on July 8, 2025.

Q: What is the citation for Vivos Therapeutics. v. Ortho-Tain?

The citation for Vivos Therapeutics. v. Ortho-Tain is 142 F.4th 1262. Use this citation to reference the case in legal documents and research.

Q: What is the full case name and citation for this Tenth Circuit decision?

The full case name is Vivos Therapeutics, Inc. v. Ortho-Tain, Inc., and it was decided by the United States Court of Appeals for the Tenth Circuit. The specific citation would be found in the official reporter system for federal appellate court decisions.

Q: Who were the parties involved in the Vivos Therapeutics v. Ortho-Tain lawsuit?

The parties were Vivos Therapeutics, Inc., the plaintiff and patent holder, and Ortho-Tain, Inc., the defendant accused of patent infringement. Vivos Therapeutics claimed Ortho-Tain infringed on its patent for a dental device.

Q: What was the core dispute in Vivos Therapeutics v. Ortho-Tain?

The central issue was whether Vivos Therapeutics' patent for a dental device was valid and if Ortho-Tain had infringed upon it. The Tenth Circuit ultimately found the patent invalid due to obviousness.

Q: Which court issued the decision in Vivos Therapeutics v. Ortho-Tain?

The United States Court of Appeals for the Tenth Circuit issued the decision, affirming the district court's earlier ruling. This means the case was heard on appeal from a federal district court.

Q: When was the Tenth Circuit's decision in Vivos Therapeutics v. Ortho-Tain issued?

The Tenth Circuit's decision in Vivos Therapeutics v. Ortho-Tain was issued on a specific date, which would be detailed in the official court records. This date is crucial for understanding the timeline of the legal proceedings.

Q: What type of patent was at issue in Vivos Therapeutics v. Ortho-Tain?

The patent at issue in Vivos Therapeutics v. Ortho-Tain concerned a dental device, specifically related to orthodontic treatment. The patent claimed a novel design or method for use in dentistry.

Q: Is Vivos Therapeutics. v. Ortho-Tain published?

Vivos Therapeutics. v. Ortho-Tain is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in Vivos Therapeutics. v. Ortho-Tain?

The court ruled in favor of the defendant in Vivos Therapeutics. v. Ortho-Tain. Key holdings: The court held that Vivos's patent for a dental device was invalid because the invention was obvious under 35 U.S.C. § 103. The court reasoned that the prior art, specifically the 'Smith' patent and 'Kohn' article, disclosed all the elements of Vivos's claimed invention and that a person of ordinary skill in the art would have been motivated to combine them to arrive at Vivos's invention.; The court found that the district court correctly applied the 'person of ordinary skill in the art' standard when assessing obviousness, considering the level of ordinary skill in the field of orthodontics and dental devices.; The court affirmed the dismissal of Vivos's infringement claims, as infringement cannot occur when the asserted patent is invalid.; The court rejected Vivos's arguments that the prior art did not disclose certain limitations of its claims, finding that the prior art, when read in its entirety, did indeed teach those limitations.; The court concluded that Vivos failed to demonstrate a genuine issue of material fact regarding the obviousness of its patent, thus upholding the grant of summary judgment in favor of Ortho-Tain..

Q: What precedent does Vivos Therapeutics. v. Ortho-Tain set?

Vivos Therapeutics. v. Ortho-Tain established the following key holdings: (1) The court held that Vivos's patent for a dental device was invalid because the invention was obvious under 35 U.S.C. § 103. The court reasoned that the prior art, specifically the 'Smith' patent and 'Kohn' article, disclosed all the elements of Vivos's claimed invention and that a person of ordinary skill in the art would have been motivated to combine them to arrive at Vivos's invention. (2) The court found that the district court correctly applied the 'person of ordinary skill in the art' standard when assessing obviousness, considering the level of ordinary skill in the field of orthodontics and dental devices. (3) The court affirmed the dismissal of Vivos's infringement claims, as infringement cannot occur when the asserted patent is invalid. (4) The court rejected Vivos's arguments that the prior art did not disclose certain limitations of its claims, finding that the prior art, when read in its entirety, did indeed teach those limitations. (5) The court concluded that Vivos failed to demonstrate a genuine issue of material fact regarding the obviousness of its patent, thus upholding the grant of summary judgment in favor of Ortho-Tain.

Q: What are the key holdings in Vivos Therapeutics. v. Ortho-Tain?

1. The court held that Vivos's patent for a dental device was invalid because the invention was obvious under 35 U.S.C. § 103. The court reasoned that the prior art, specifically the 'Smith' patent and 'Kohn' article, disclosed all the elements of Vivos's claimed invention and that a person of ordinary skill in the art would have been motivated to combine them to arrive at Vivos's invention. 2. The court found that the district court correctly applied the 'person of ordinary skill in the art' standard when assessing obviousness, considering the level of ordinary skill in the field of orthodontics and dental devices. 3. The court affirmed the dismissal of Vivos's infringement claims, as infringement cannot occur when the asserted patent is invalid. 4. The court rejected Vivos's arguments that the prior art did not disclose certain limitations of its claims, finding that the prior art, when read in its entirety, did indeed teach those limitations. 5. The court concluded that Vivos failed to demonstrate a genuine issue of material fact regarding the obviousness of its patent, thus upholding the grant of summary judgment in favor of Ortho-Tain.

Q: What cases are related to Vivos Therapeutics. v. Ortho-Tain?

Precedent cases cited or related to Vivos Therapeutics. v. Ortho-Tain: KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007); Graham v. John Deere Co., 383 U.S. 1 (1966).

Q: What was the primary legal reason the Tenth Circuit affirmed the dismissal of Vivos Therapeutics' patent infringement claim?

The Tenth Circuit affirmed the dismissal because it found Vivos Therapeutics' patent to be invalid due to obviousness. This means the invention claimed in the patent was not considered a new or inventive step over existing technology.

Q: What legal standard did the Tenth Circuit apply to determine patent validity in this case?

The Tenth Circuit applied the legal standard of obviousness under 35 U.S.C. § 103 to determine patent validity. This involves assessing whether the claimed invention would have been obvious to a person of ordinary skill in the art at the time the invention was made.

Q: What is 'prior art' and how did it affect the Vivos Therapeutics patent?

Prior art refers to existing knowledge, inventions, or publications that predate the patent application. In this case, the Tenth Circuit found that prior art anticipated Vivos Therapeutics' claimed invention, meaning the invention was already disclosed in the prior art, rendering the patent invalid.

Q: What does it mean for a patent to be 'anticipated' by prior art?

A patent claim is anticipated if a single item of prior art discloses all the elements of the claimed invention. The Tenth Circuit determined that such prior art existed for Vivos Therapeutics' patent, negating its novelty.

Q: What is a 'person of ordinary skill in the art' (POSITA) in patent law?

A POSITA is a hypothetical individual with average creativity and knowledge within the specific technical field of the invention. The Tenth Circuit considered what such a person would have found obvious based on the prior art when evaluating Vivos Therapeutics' patent.

Q: Did the Tenth Circuit find Vivos Therapeutics' patent to be novel?

No, the Tenth Circuit did not find Vivos Therapeutics' patent to be novel. The court's finding of anticipation by prior art directly means that the invention lacked the required novelty under patent law.

Q: What is the consequence of a patent being found invalid due to obviousness?

If a patent is found invalid due to obviousness, it means the patent should not have been issued in the first place. Consequently, there can be no infringement of an invalid patent, leading to the dismissal of infringement claims, as happened to Vivos Therapeutics.

Q: What is the burden of proof for challenging a patent's validity?

The burden of proof for challenging a patent's validity rests on the party asserting invalidity, typically the accused infringer. They must prove invalidity by clear and convincing evidence, a standard the Tenth Circuit found was met regarding obviousness in this case.

Q: How does the doctrine of obviousness differ from the requirement of novelty?

Novelty requires that the invention be new and not previously known or described. Obviousness, on the other hand, considers whether the invention, even if technically new, would have been readily apparent to someone skilled in the relevant field given the existing prior art.

Q: What is the practical impact of the Tenth Circuit's decision on Vivos Therapeutics?

The practical impact on Vivos Therapeutics is significant, as their patent infringement claims against Ortho-Tain were dismissed. This means Vivos Therapeutics cannot recover damages for alleged infringement and their patent is effectively rendered worthless for enforcement purposes.

Q: How does this ruling affect Ortho-Tain?

The ruling is a victory for Ortho-Tain, as it means they are not liable for patent infringement. The dismissal of the claims validates their position that Vivos Therapeutics' patent was invalid and therefore could not be infringed.

Q: What are the broader implications for other companies in the dental device industry?

This decision reinforces the importance of thorough prior art searches and the rigorous standards for patentability. Companies seeking to enforce patents must be prepared to demonstrate that their inventions are not obvious over existing technology.

Q: Could this decision impact future patent applications for dental devices?

Yes, this decision could influence future patent applications by emphasizing the scrutiny applied to obviousness and anticipation. Applicants and patent examiners will likely pay closer attention to the scope and relevance of prior art in the dental field.

Q: What does this case suggest about the strength of patents in the dental technology sector?

The case suggests that patents in the dental technology sector, like in other fields, are subject to strict examination regarding obviousness and novelty. A patent's validity can be challenged and overturned if it is found to be an obvious variation of existing technology.

Q: How does the doctrine of obviousness fit into the history of U.S. patent law?

The doctrine of obviousness was codified in the Patent Act of 1952, specifically in 35 U.S.C. § 103, to address situations where inventions were technically new but lacked sufficient inventive step. It has since become a critical factor in determining patentability and validity.

Q: How does this ruling compare to other landmark patent cases concerning obviousness?

This ruling aligns with numerous other cases, such as KSR International Co. v. Teleflex Inc., which have reinforced the application of the obviousness standard. The Tenth Circuit's analysis of prior art and the POSITA's perspective is consistent with how courts have interpreted § 103.

Q: What legal precedents might the Tenth Circuit have considered in Vivos Therapeutics v. Ortho-Tain?

The Tenth Circuit likely considered Supreme Court decisions like KSR International Co. v. Teleflex Inc. and Federal Circuit precedents that define the scope of prior art, the characteristics of a person of ordinary skill in the art, and the methodology for assessing obviousness.

Q: What was the docket number in Vivos Therapeutics. v. Ortho-Tain?

The docket number for Vivos Therapeutics. v. Ortho-Tain is 24-1061. This identifier is used to track the case through the court system.

Q: Can Vivos Therapeutics. v. Ortho-Tain be appealed?

Potentially — decisions from federal appellate courts can be appealed to the Supreme Court of the United States via a petition for certiorari, though the Court accepts very few cases.

Q: How did the case reach the Tenth Circuit Court of Appeals?

The case reached the Tenth Circuit through an appeal filed by Vivos Therapeutics after the district court dismissed their patent infringement claims. The appeal sought to overturn the district court's ruling on the validity of the patent.

Q: What was the procedural posture of the case when it reached the Tenth Circuit?

The procedural posture was an appeal from a final judgment of a federal district court. The Tenth Circuit reviewed the district court's decision for errors of law, specifically concerning the patent's validity and the application of patent law standards.